Persbericht: Programma bekend van gebruikersevent GiLab Commit 2019
Amsterdam — 30 augustus 2019 — GitLab, het DevOps platform,... Lees verder →
- 'Approved' for treatment purpose usage at Yonsei University Hospital after Seoul National University Hospital, Yeungnam University Hospital and Chungnam National University ...
Lees verderLEIDEN, Netherlands, March 27, 2020 /PRNewswire/ -- Pharming announces the Committee for Medicinal Products for Human Use (CHMP), an advisory committee of the European Medicine ...
Lees verderNot intended for US, Canada and UK-based media -- EU approval based on JAVELIN Renal 101 trial results demonstrating significant improvement in progression-free survival with ...
Lees verderBRUSSELS and THOUSAND OAKS, California, Oct. 18, 2019 /PRNewswire/ -- UCB and Amgen today announced that following a re-examination procedure, the Committee for Medicinal ...
Lees verderMILAN and BASEL, Switzerland, Sept. 2, 2019 /PRNewswire/ -- A new highly selective treatment, a peroxisome proliferator-activated receptor alpha modulator (SPPARM-alpha) ...
Lees verderNEW YORK and LONDON, April 18, 2019 /PRNewswire/ -- TAU BIO-LOGIC CORP. announced today that in collaboration with the UK-based group LifeArc, it has successfully humanized a ...
Lees verderMarket Development Veteran Lisa Rogan Joins Nuvaira's Executive Team MINNEAPOLIS, Feb 11, 2019 /PRNewswire/ -- Nuvaira , a developer of novel therapeutic medical devices to ...
Lees verderTOKYO, September 21, 2018 /PRNewswire/ -- If approved, mogamulizumab would be the first biologic agent targeting CCR4 to be available for patients in Europe. Kyowa Hakko ...
Lees verderLISLE, Illinois, Sept. 14, 2018 /PRNewswire/ -- Endotronix, Inc. , a digital health, medtech company dedicated to advancing the treatment of heart failure, today announced the ...
Lees verderTOKYO, August 8, 2018 /PRNewswire/ -- - Poteligeo has been approved for the treatment of the two most common types of Cutaneous T-cell lymphoma (CTCL) in ...
Lees verder